SNDL vs. ATNFW, SXTPW, ACONW, AIMDW, DRTSW, ALVOW, ALVO, AONCW, AONC, and APLMW
Should you be buying SNDL stock or one of its competitors? The main competitors of SNDL include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Aclarion (ACONW), Ainos (AIMDW), Alpha Tau Medical (DRTSW), Alvotech (ALVOW), Alvotech (ALVO), American Oncology Network (AONCW), American Oncology Network (AONC), and Apollomics (APLMW). These companies are all part of the "medical" sector.
180 Life Sciences (NASDAQ:ATNFW) and SNDL (NASDAQ:SNDL) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their media sentiment, analyst recommendations, profitability, community ranking, earnings, risk, institutional ownership, dividends and valuation.
SNDL received 140 more outperform votes than 180 Life Sciences when rated by MarketBeat users.
180 Life Sciences has higher earnings, but lower revenue than SNDL.
SNDL has a consensus price target of $4.00, indicating a potential upside of 62.60%. Given 180 Life Sciences' higher possible upside, analysts clearly believe SNDL is more favorable than 180 Life Sciences.
In the previous week, SNDL had 2 more articles in the media than 180 Life Sciences. MarketBeat recorded 3 mentions for SNDL and 1 mentions for 180 Life Sciences. 180 Life Sciences' average media sentiment score of 0.45 beat SNDL's score of 0.00 indicating that SNDL is being referred to more favorably in the news media.
180 Life Sciences has a net margin of 0.00% compared to 180 Life Sciences' net margin of -14.99%. SNDL's return on equity of 0.00% beat 180 Life Sciences' return on equity.
Summary
SNDL beats 180 Life Sciences on 6 of the 9 factors compared between the two stocks.
Get SNDL News Delivered to You Automatically
Sign up to receive the latest news and ratings for SNDL and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding SNDL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
